Abiopharma

🔍 WILLIS CHARLES F IV (Executive)

Company: WILLIS LEASE FINANCE CORP (WLFC)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Sold 42,950 shares of Common Stock at $175.62 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: false | shares_owned_after: 881,281.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: Spouse | shares_owned_after: 13,560.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: CFW Partners | shares_owned_after: 2,134,148.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: Granddaughter | shares_owned_after: 584.00 | Footnotes: F3

Footnotes:

• F1: Return to Issuer of previously restricted shares to satisfy withholding tax liability.
• F2: Charlotte Montressor Willis.
• F3: Wilder Grace Willis 2016 Trust.